EUVIMEDDescubrir EUVIMED
Crossref

Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease

Jack Price

Murdoch University Research Portal · 2025-01-01

DOI: 10.60867/00000078 ↗

At a glance

Journal article in Murdoch University Research Portal, published on 2025-01-01. Written by Jack Price.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Parkinson’s Disease (PD) is a progressive, neurodegenerative condition that is increasing in prevalence globally. PD is marked by a loss of dopaminergic neurons in the brain, but system-wide metabolic disturbances are now understood to contribute to disease aetiogenesis. Importantly, whilst the clinical presentation of PD is highly heterogenous, a metabolic basis for stratification into different subtypes is lacking. As such, readily accessible biomarkers of PD that can give insight into disease status are highly sought after to address shortcomings in existing approaches that result in poor diagnostic accuracy, minimal treatment options, and a limited understanding of the disease process.

Subjects

Parkinson's diseaselipid remodelinglipidomicsbiomarkersmetabolic disordersdopaminergic neuronsdisease stratificationneurodegeneration

Cite

APA

Price, J. (2025). Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease. Murdoch University Research Portal. https://doi.org/10.60867/00000078

Vancouver

Price J. Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease. Murdoch University Research Portal. 2025. doi:10.60867/00000078

BibTeX
@article{Price2025,
  author = {Price, Jack},
  title = {Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease},
  journal = {Murdoch University Research Portal},
  year = {2025},
  doi = {10.60867/00000078}
}
Start for free →